Lack of Increased Frequency of Human Immunodeficiency Virus Infection in Individuals with Dengue-like Illness in South India
Dear Editor,
The WHO/UNAIDS estimates 5.1 million individuals infected with human immunodeÞ ciency virus (HIV) in India. 1 It is estimated that 60-80% of the HIV infected individuals can have seroconversion illness which may mimic an acute viral infection with fever and rash.
2,3 India has an ongoing HIV epidemic with seasonal outbreaks of dengue fever, one of the most common causes of fever with rash. The objective of this study was to determine the frequency of HIV infection among patients clinically presenting with dengue-like illness, to determine the need for testing HIV antibodies in denguelike illness. of primary and secondary dengue virus infection. The HIV antibody was screened by a third generation HIV enzymelinked immunosorbent assay (ELISA), the Genscreen (BioRad, Marnes La Coquette, France). Since this kit is a third generation ELISA it could pickup IgM antibody apart from IgG. The same ELISA in duplicate retested all the positive samples wherever sample volume was sufÞ cient. Samples which were of insufÞ cient volume but had tested positive either once or more than once in ELISA, were tested by an immunoblot (CHIRON RIBA, HIV-1/ HIV-2 SIA, Chiron Corporation, CA, USA) assay for confirmation of HIV status.
Among 326 samples, 292 were negative for dengue IgG and IgM antibodies while the remaining 34 samples were positive for dengue IgM antibodies. Nine (3.1%) of the 292 dengue negative samples were reactive for HIV by ELISA, only 3 (1%) were conÞ rmed by immunoblot. Four (11.8%) of the 34 dengue IgM antibody positive samples were reactive for HIV by ELISA. All these four samples were positive only Correspondence for dengue IgM antibody. The immunoblot conÞ rmed two of these samples as HIV negative and the remaining two as indeterminate. The data is shown in the Table. In this study we used HIV antibody assays (ELISA and immunoblot) that can detect IgM antibodies. The immunoblot detects the IgM antibdoy as the conjugate used in the assay was peroxidase-labeled goat anti-human IgG against heavy and light chains. A frequency of 0.92% HIV antibody positive status was observed among individuals presenting with dengue like illness. During the same period an HIV frequency of 2.22-1.38% was seen in a hospital-based population. In a recent community based study conducted in Vellore district and in the urban wards of Vellore town 1512 serum samples were tested from subjects residing in rural areas and 1358 samples from urban areas collected during 1999-2000 for HIV antibodies. The overall HIV prevalence was 1% with a lower seropositivity among rural samples (0.66%) than urban (1.4%).
4
Though the seroconversion illness can present as denguelike illness we could not Þ nd any increase in the frequency of HIV infection. Among the dengue IgM positive samples, two showed indeterminate results. Those two patients may have been in the seroconversion period as both showed reactivity to P24 antibody by immunoblot. It is known that some individuals who exhibit indeterminate results (e.g. reactivity to p24 and p55) later seroconvert, demonstrating that a p24 and p55 immunoblot proÞ le can indicate early infection. However, these Þ ndings have to be viewed carefully as this may be a false positive reactivity. There are reports of HIV false reactivity in dengue positive patients. 5 In conclusion, our study failed to show any increase in frequency of HIV infection among individuals presenting with dengue-like illness and it may not be necessary to screen for HIV seroconversion illness. However, primary HIV infection can be established by retesting for HIV antibody after about one month following sero-conversion illness.
3 This may be an approach for individuals who belong to HIV risk groups including sexually promiscuous individuals.
